Prior Anticoagulation in Patients with Ischemic Stroke and Atrial Fibrillation

被引：88

作者：

Meinel, Thomas R. ^{[1
,2
]}

Branca, Mattia ^{[3
]}

De Marchis, Gian Marco ^{[4
,5
,6
]}

Nedeltchev, Krassen ^{[7
]}

Kahles, Timo ^{[7
]}

Bonati, Leo ^{[4
,5
,6
]}

Arnold, Marcel ^{[1
,2
]}

Heldner, Mirjam R. ^{[1
,2
]}

Jung, Simon ^{[1
,2
]}

Carrera, Emmanuel ^{[8
]}

Dirren, Elisabeth ^{[8
]}

Michel, Patrik ^{[9
]}

Strambo, Davide ^{[9
]}

Cereda, Carlo W. ^{[10
]}

Bianco, Giovanni ^{[10
]}

Kagi, Georg ^{[11
]}

Vehoff, Jochen ^{[11
]}

Katan, Mira ^{[12
]}

Bolognese, Manuel ^{[13
]}

Backhaus, Roland ^{[14
]}

Salmen, Stephan ^{[15
]}

Albert, Sylvan ^{[16
]}

Medlin, Friedrich ^{[17
]}

Berger, Christian ^{[18
]}

Schelosky, Ludwig ^{[19
]}

Renaud, Susanne ^{[20
]}

Niederhauser, Julien ^{[21
]}

Bonvin, Christophe ^{[22
]}

Schaerer, Michael ^{[23
]}

Mono, Marie-Luise ^{[24
]}

Rodic, Biljana ^{[25
]}

Tarnutzer, Alexander A. ^{[26
]}

Mordasini, Pasquale ^{[2
,27
]}

Gralla, Jan ^{[2
,27
]}

Kaesmacher, Johannes ^{[2
,28
]}

Engelter, Stefan ^{[4
,5
,6
,29
]}

Fischer, Urs ^{[1
,2
]}

Seiffge, David J. ^{[1
,2
]}

机构：

[1] Bern Univ Hosp, Inselspital, Dept Neurol, Bern, Switzerland

[2] Univ Bern, Bern, Switzerland

[3] Univ Bern, Clinicial Trials Unit Bern, Bern, Switzerland

[4] Univ Hosp Basel, Dept Neurol, Basel, Switzerland

[5] Univ Hosp Basel, Stroke Ctr, Basel, Switzerland

[6] Univ Basel, Basel, Switzerland

[7] Kantonsspital Aarau, Dept Neurol, Aarau, Switzerland

[8] Hop Univ Geneve, Dept Neurol, Geneva, Switzerland

[9] Lausanne Univ Hosp, Stroke Ctr, Neurol Serv, Lausanne, Switzerland

[10] Neuroctr Southern Switzerland, Stroke Ctr, Lugano, Switzerland

[11] Kantonsspital St Gallen, Dept Neurol, St Gallen, Switzerland

[12] Univ Hosp Zurich, Dept Neurol, Basel, Switzerland

[13] Cantonal Hosp Lucerne, Neuroctr, Luzern, Switzerland

[14] Hirslanden Hosp Zurich, Glattpark, Switzerland

[15] Spitalzentrum Biel, Biel, Switzerland

[16] Cantonal Hosp Graubuenden, Chur, Switzerland

[17] Cantonal Hosp Fribourg, Stroke Unit, Fribourg, Switzerland

[18] Spital Sarganserland Grabs, Grabs, Switzerland

[19] Cantonal Hosp Munsterlingen, Neurol, Munsterlingen, Switzerland

[20] Cantonal Hosp Neuchatel, Neurol, Neuchatel, Switzerland

[21] Grp Hosp Ouest Leman, Stroke Unit, Nyon, Switzerland

[22] Hop Valais, Sion, Switzerland

[23] Burgerspital, Solothurn, Switzerland

[24] Stadtspital Waid & Triemli, Zurich, Switzerland

[25] Cantonal Hosp Winterthur, Winterthur, Switzerland

[26] Cantonal Hosp Baden, Baden, Switzerland

[27] Bern Univ Hosp, Inselspital, Inst Diagnost & Intervent Neuroradiol, Bern, Switzerland

[28] Bern Univ Hosp, Inselspital, Inst Diagnost & Intervent Neuroradiol, Inst Diagnost Intervent & Pediat Radiol,Dept Neur, Bern, Switzerland

[29] Univ Basel, Univ Dept Geriat Med Felix Platter, Neurol & Neurorehabil, Basel, Switzerland

来源：

ANNALS OF NEUROLOGY | 2021年 / 89卷 / 01期

关键词：

PRECEDING ANTITHROMBOTIC TREATMENT; ANTAGONIST ORAL ANTICOAGULANTS; INTRAVENOUS THROMBOLYSIS; PLASMA-LEVELS; EMERGENCY MANAGEMENT; REPERFUSION THERAPY; DABIGATRAN; SEVERITY; SAFETY; COMPLICATIONS;

D O I：

10.1002/ana.25917

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Objective The aim was to evaluate, in patients with atrial fibrillation (AF) and acute ischemic stroke, the association of prior anticoagulation with vitamin K antagonists (VKAs) or direct oral anticoagulants (DOACs) with stroke severity, utilization of intravenous thrombolysis (IVT), safety of IVT, and 3-month outcomes. Methods This was a cohort study of consecutive patients (2014-2019) on anticoagulation versus those without (controls) with regard to stroke severity, rates of IVT/mechanical thrombectomy, symptomatic intracranial hemorrhage (sICH), and favorable outcome (modified Rankin Scale score 0-2) at 3 months. Results Of 8,179 patients (mean [SD] age, 79.8 [9.6] years; 49% women), 1,486 (18%) were on VKA treatment, 1,634 (20%) on DOAC treatment at stroke onset, and 5,059 controls. Stroke severity was lower in patients on DOACs (median National Institutes of Health Stroke Scale 4, [interquartile range 2-11]) compared with VKA (6, [2-14]) and controls (7, [3-15],p < 0.001; quantile regression: beta -2.1, 95% confidence interval [CI] -2.6 to -1.7). The IVT rate in potentially eligible patients was significantly lower in patients on VKA (156 of 247 [63%]; adjusted odds ratio [aOR] 0.67; 95% CI 0.50-0.90) and particularly in patients on DOACs (69 of 464 [15%]; aOR 0.06; 95% CI 0.05-0.08) compared with controls (1,544 of 2,504 [74%]). sICH after IVT occurred in 3.6% (2.6-4.7%) of controls, 9 of 195 (4.6%; 1.9-9.2%; aOR 0.93; 95% CI 0.46-1.90) patients on VKA and 2 of 65 (3.1%; 0.4-10.8%, aOR 0.56; 95% CI 0.28-1.12) of those on DOACs. After adjustments for prognostic confounders, DOAC pretreatment was associated with a favorable 3-month outcome (aOR 1.24; 1.01-1.51). Interpretation Prior DOAC therapy in patients with AF was associated with decreased admission stroke severity at onset and a remarkably low rate of IVT. Overall, patients on DOAC might have better functional outcome at 3 months. Further research is needed to overcome potential restrictions for IVT in patients taking DOACs. ANN NEUROL 2020

引用

页码：42 / 53

页数：12

共 50 条

[21] Factors Associated with Ischemic Stroke on Therapeutic Anticoagulation in Patients with Nonvalvular Atrial Fibrillation
Kim, Young Dae
Lee, Kyung Yul
Nam, Hyo Suk
Han, Sang Won
Lee, Jong Yun
Cho, Han-Jin
Kim, Gyu Sik
Kim, Seo Hyun
Cha, Myoung-Jin
Ahn, Seong Hwan
Oh, Seung-Hun
Lee, Kee Ook
Jung, Yo Han
Choi, Hye-Yeon
Han, Sang-Don
Lee, Hye Sun
Nam, Chung Mo
Kim, Eun Hye
Lee, Ki Jeong
Song, Dongbeom
Park, Hui-Nam
Heo, Ji Hoe
YONSEI MEDICAL JOURNAL, 2015, 56 (02) : 410 - 417
[22] Anticoagulation in Patients with Acute Ischemic Stroke and Atrial Fibrillation—a Balance of Risks and Benefits
Abhimanyu Beri
Sujeeth Reddy Punnam
Cardiovascular Drugs and Therapy, 2008, 22 : 419 - 425
[23] Timing Of Anticoagulation After Ischemic Stroke In Patients With Atrial Fibrillation: An International Survey
Alrohimi, Anas
Kate, Mahesh P.
Thirunavukkarasu, Sibi
Jeerakathil, Thomas
Jickling, Glen
Shuaib, Ashfaq
Buck, Brian H.
Butcher, Ken
STROKE, 2022, 53
[24] Disparities and Temporal Trends in the Use of Anticoagulation in Patients With Ischemic Stroke and Atrial Fibrillation
Sur, Nicole B.
Wang, Kefeng
Di Tullio, Marco R.
Gutierrez, Carolina M.
Dong, Chuanhui
Koch, Sebastian
Gardener, Hannah
Garcia-Rivera, Enid J.
Zevallos, Juan Carlos
Burgin, W. Scott
Rose, David Z.
Goldberger, Jeffrey J.
Romano, Jose G.
Sacco, Ralph L.
Rundek, Tatjana
STROKE, 2019, 50 (06) : 1452 - 1459
[25] QUALITY OF LIFE AND ANTICOAGULATION IN ATRIAL FIBRILLATION PATIENTS POST-ISCHEMIC STROKE
Beckie, Theresa M.
Deng, Wei
Tran, Nhi
Adler, Evan
Renati, Swetha
Rose, David
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 217 - 217
[26] Left Atrial Enlargement is Associated With Anticoagulation Failure in Patients With Acute Ischemic Stroke and Atrial Fibrillation
Dakay, Katarina
Chang, Andrew D.
Hemendinger, Morgan
Cutting, Shawna M.
McTaggart, Ryan A.
Jayaraman, Mahesh V.
Chu, Antony
Panda, Nikhil
Song, Christopher
Merkler, Alexander
Gialdini, Gino
Kummer, Benjamin
Lerario, Michael P.
Kamel, Hooman
Elkind, Mitchell S.
Furie, Karen L.
Yaghi, Shadi
STROKE, 2018, 49
[27] Anticoagulation: Stroke Prevention in Patients with Atrial Fibrillation
Waldo, Albert L.
CARDIOLOGY CLINICS, 2009, 27 (01) : 125 - +
[28] Anticoagulation: Stroke prevention in patients with atrial fibrillation
Waldo, Albert L.
MEDICAL CLINICS OF NORTH AMERICA, 2008, 92 (01) : 143 - +
[29] Timing of Anticoagulation Post Atrial Fibrillation Related Ischemic Stroke
Plecash, Alyson
Mann, Sahil
Benavente, Oscar
Yip, Samuel
NEUROLOGY, 2020, 94 (15)
[30] Prior Anticoagulation and Short- or Long-Term Clinical Outcomes in Ischemic Stroke or Transient Ischemic Attack Patients With Nonvalvular Atrial Fibrillation
Tokunaga, Keisuke
Koga, Masatoshi
Itabashi, Ryo
Yamagami, Hiroshi
Todo, Kenichi
Yoshimura, Sohei
Kimura, Kazumi
Sato, Shoichiro
Terasaki, Tadashi
Inoue, Manabu
Shiokawa, Yoshiaki
Takagi, Masahito
Kamiyama, Kenji
Tanaka, Kanta
Takizawa, Shunya
Shiozawa, Masayuki
Okuda, Satoshi
Okada, Yasushi
Kameda, Tomoaki
Nagakane, Yoshinari
Hasegawa, Yasuhiro
Shibuya, Satoshi
Ito, Yasuhiro
Matsuoka, Hideki
Takamatsu, Kazuhiro
Nishiyama, Kazutoshi
Kario, Kazuomi
Yagita, Yoshiki
Fujita, Kyohei
Ando, Daisuke
Kumamoto, Masaya
Arihiro, Shoji
Toyoda, Kazunori
Takasugi, Junji
Higashida, Kyoko
Sakamoto, Yuki
Hirano, Teruyuki
Suzuki, Rieko
Nakagawara, Jyoji
Homma, Kazunari
Tanaka, Eijirou
Akiyama, Hisanao
Mochizuki, Hiroshi
Nakashima, Takahiro
Shibazaki, Kensaku
Furui, Eisuke
Maeda, Koichiro
Endo, Kaoru
Miyagi, Tetsuya
Osaki, Masato
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2019, 8 (03):

← 1 2 3 4 5 →